Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia


ALADAĞ KARAKULAK E. , Aktimur S. H. , Aydin O., DEMİROĞLU H. , BÜYÜKAŞIK Y. , AKSU S. , ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, sa.3, ss.147-153, 2021 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Konu: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.clml.2020.12.014
  • Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Sayfa Sayıları: ss.147-153

Özet

We retrospectively compared 47 acute lymphoblastic leukemia (ALL) patients who received Berlin-Frankfurt-Munster chemotherapy and 83 ALL. patients who underwent allogeneic hematopoietic stem-cell transplantation (AHSCT). While there was no difference in overall survival between the 2 groups, disease-free survival was found to be significantly higher in the AHSCT group.